Cargando…

Cancer immunotherapy with multiple tumor antigen activated autologous T cells in patients with HBV related hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Han, Yanyan, Tao, Ran, Huang, Jin, Guo, Yabing, Wu, Dongyun, Liao, Yujing, Li, Jin, Zhou, Xiangjun, Hou, Jinlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292537/ http://dx.doi.org/10.1186/2051-1426-2-S3-P245

Ejemplares similares

Immunotherapy with patient-specific antigens selection reduced the metastasis of a cervical cancer patient
por: Han, Yanyan, et al.
Publicado: (2015)

Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy
por: Han, Yanyan, et al.
Publicado: (2017)

Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B positive patients with hepatocellular carcinoma
por: Bayer, Michael, et al.
Publicado: (2014)

Multiple Antigen Stimulating Cellular Therapy (MASCT) For Hepatocellular Carcinoma After Curative Treatment: A Retrospective Study
por: He, Yajing, et al.
Publicado: (2018)

Lm-LLO immunotherapies targeting multiple antigens and their impact on different mechanisms in the tumor microenvironment
por: Wallecha, Anu, et al.
Publicado: (2014)

Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
por: Nair, Smita K, et al.
Publicado: (2013)

Single-step nanoparticle antigen presentation system for tumor immunotherapy
por: Kohlhapp, Frederick, et al.
Publicado: (2015)

Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer
por: Kandalaft, Lana E, et al.
Publicado: (2013)

P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes
por: Krebs, K, et al.
Publicado: (2014)

Naive CD8+ T cells from ART respond to primary vaccination against autologous HIV-1 antigen
por: Smith, Kellie N, et al.
Publicado: (2012)

HBV and HCV genotypes distribution on the territory of Belarus
por: Gasich, EL, et al.
Publicado: (2012)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

A simple and robust clinical manufacturing process for the ex-vivo expansion of autologous T cells genetically engineered to express an anti-BCMA chimeric antigen receptor (CAR) for the treatment of multiple myeloma
por: Ladd, Alden, et al.
Publicado: (2015)

Enrichment and expansion with nanoscale artificial antigen presenting cells for T cell adoptive immunotherapy
por: Perica, Karlo, et al.
Publicado: (2014)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Prevalence of HBV infection in immunocompromised patients on ART nearly equals HBV mono infection in individuals not infected with HIV, Shimla Northern India
por: Garg, Aarti, et al.
Publicado: (2014)

Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
por: Kelderman, Sander, et al.
Publicado: (2013)

Predominance of HBV genotype D in southern part of India
por: Narayanan, Kalyanaraman, et al.
Publicado: (2014)

Predictive factors of response to interferon in chronic HBV hepatitis
por: Popescu, Cristina, et al.
Publicado: (2014)

Multi-functional cytotoxic T cell expansion correlates with overall survival after administration of autologous dendritic cell immunotherapy in renal cell cancer patients
por: DeBenedette, M, et al.
Publicado: (2013)

P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
por: Dargel, C, et al.
Publicado: (2014)

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers
por: Holmen Olofsson, Gitte, et al.
Publicado: (2014)

A transgenic mouse model for studying HBV infection in neonate
por: Wang, Zhuo, et al.
Publicado: (2011)

Expression of cancer testis antigens and its correlation with clinicopathological parameters in hepatocellular carcinoma
por: Wang, Meng, et al.
Publicado: (2013)

P19-45. Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens
por: Cobb, AJ, et al.
Publicado: (2009)

Individual cultures of melanoma tumor infiltrating lymphocytes possess distinct patterns of reactivity with mutated antigens identified by whole exome sequencing of autologous tumors
por: Crystal, Jessica S, et al.
Publicado: (2014)

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer
por: Beer, Tomasz M, et al.
Publicado: (2015)

Prevalence of HCV, HBV and HIV infections in patients and staff of haemodialysis unit
por: Palanisamy, Saraswathy, et al.
Publicado: (2012)

Prevalence of HBV and HIV coinfection from an infectious disease hospital in Mumbai
por: Shastri, Jayanthi, et al.
Publicado: (2014)

Therapeutic approach to patients with rheumatoid arthritis and chronic HBV/HCV infection
por: Daia-Iliescu, Sînziana, et al.
Publicado: (2014)

Autologous Blood Injection Therapy for tendinopathy
por: Frankowski, Olga
Publicado: (2010)

Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model
por: Berger, S Carolina, et al.
Publicado: (2014)

Transmission of HIV, HBV, HCV in health settings: an anthropological approach on hygiene in Cambodia
por: Hancart-Petitet, Pascale, et al.
Publicado: (2011)

Liver damage in HIV+HBV co-infected patients determined by transient elastography
por: Dumea, Elena, et al.
Publicado: (2014)

P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy
por: Sconocchia, G, et al.
Publicado: (2014)

P-207: Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
por: Charalampous, Charalampos, et al.
Publicado: (2022)

Pilot trial of a type I - polarized autologous dendritic cell vaccine incorporating tumor blood vessel antigen-derived peptides in patients with metastatic breast cancer
por: Baar, Joseph, et al.
Publicado: (2015)

Association of IFN-γ gene polymorphism and levels in HBV related disease chronicity in India
por: Saxena, Roli, et al.
Publicado: (2012)

The results of a study on the prevalence of HIV, HCV and HBV genotypes in some regions of Ukraine
por: Yurchenko, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tq44rg83efl8boeghkmrr2c8hg